Show simple item record

dc.contributor.authorKapoor, Alok
dc.contributor.authorBloomstone, Sarah
dc.contributor.authorJaved, Saud
dc.contributor.authorMaheswaran, Abiramy
dc.contributor.authorNagy, Ahmed
dc.contributor.authorElhag, Rasha
dc.contributor.authorHoung, Diana
dc.contributor.authorDarling, Chad E.
dc.contributor.authorMcManus, David D.
dc.contributor.authorBarton, Bruce A.
dc.contributor.authorMazor, Kathleen M.
dc.date2022-08-11T08:09:55.000
dc.date.accessioned2022-08-23T16:48:47Z
dc.date.available2022-08-23T16:48:47Z
dc.date.issued2020-01-22
dc.date.submitted2020-02-18
dc.identifier.citation<p>Kapoor A, Bloomstone S, Javed S, Silva M, Lynch A, Yogaratnam D, Carlone B, Springer K, Maheswaran A, Chen X, Nagy A, Elhag R, Markaddy E, Aungst T, Bartlett D, Houng D, Darling C, McManus D, Herzig SJ, Barton B, Mazor K. Reducing Hospitalizations and Emergency Department Visits in Patients With Venous Thromboembolism Using a Multicomponent Care Transition Intervention. Inquiry. 2020 Jan-Dec;57:46958019900080. doi: 10.1177/0046958019900080. PMID: 31965873; PMCID: PMC6977209. <a href="https://doi.org/10.1177/0046958019900080">Link to article on publisher's site</a></p>
dc.identifier.issn0046-9580 (Linking)
dc.identifier.doi10.1177/0046958019900080
dc.identifier.pmid31965873
dc.identifier.urihttp://hdl.handle.net/20.500.14038/41334
dc.description<p>Full author list omitted for brevity. For the full list of authors, see article.</p>
dc.description.abstractPreventing utilization of hospital and emergency department after diagnosis of venous thromboembolism is a complex problem. The objective of this study is to assess the impact of a care transition intervention on hospitalizations and emergency department visits after venous thromboembolism. We randomized adults diagnosed with a new episode of venous thromboembolism to usual care or a multicomponent intervention that included a home pharmacist visit in the week after randomization (typically occurring at time of discharge), illustrated medication instructions distributed during home visit, and a follow-up phone call with an anticoagulation expert scheduled for 8 to 30 days from time of randomization. Through physician chart review of the 90 days following randomization, we measured the incidence rate of hospital and emergency department visits for each group and their ratio. We also determined which visits were related to recurrent venous thromboembolism, bleeding, or anticoagulation and which where preventable. We enrolled 77 intervention and 85 control patients. The incidence rate was 4.50 versus 6.01 visits per 1000 patient days in the intervention versus control group (incidence rate ratio = 0.71; 95% confidence interval = 0.40-1.27). Most visits in the control group were not related to venous thromboembolism or bleeding (21%) and of those that were, most were not preventable (25%). The adjusted incidence rate ratio for the intervention was 1.05 (95% confidence interval = 0.57-1.91). Our patients had a significant number of hospital and emergency department visits after diagnosis. Most visits were not related to recurrent venous thromboembolism or bleeding and of those that were, most were not preventable. Our multicomponent intervention did not decrease hospitalizations and emergency department visits.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=31965873&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright © The Author(s) 2020. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectUMCCTS funding
dc.subjectanticoagulation
dc.subjectclinical pharmacy
dc.subjecthome care services
dc.subjectpatient education
dc.subjectpreventative medicine
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.subjectEmergency Medicine
dc.subjectHealth Services Administration
dc.subjectPreventive Medicine
dc.titleReducing Hospitalizations and Emergency Department Visits in Patients With Venous Thromboembolism Using a Multicomponent Care Transition Intervention
dc.typeJournal Article
dc.source.journaltitleInquiry : a journal of medical care organization, provision and financing
dc.source.volume57
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=5138&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/4119
dc.identifier.contextkey16574431
refterms.dateFOA2022-08-23T16:48:47Z
html.description.abstract<p>Preventing utilization of hospital and emergency department after diagnosis of venous thromboembolism is a complex problem. The objective of this study is to assess the impact of a care transition intervention on hospitalizations and emergency department visits after venous thromboembolism. We randomized adults diagnosed with a new episode of venous thromboembolism to usual care or a multicomponent intervention that included a home pharmacist visit in the week after randomization (typically occurring at time of discharge), illustrated medication instructions distributed during home visit, and a follow-up phone call with an anticoagulation expert scheduled for 8 to 30 days from time of randomization. Through physician chart review of the 90 days following randomization, we measured the incidence rate of hospital and emergency department visits for each group and their ratio. We also determined which visits were related to recurrent venous thromboembolism, bleeding, or anticoagulation and which where preventable. We enrolled 77 intervention and 85 control patients. The incidence rate was 4.50 versus 6.01 visits per 1000 patient days in the intervention versus control group (incidence rate ratio = 0.71; 95% confidence interval = 0.40-1.27). Most visits in the control group were not related to venous thromboembolism or bleeding (21%) and of those that were, most were not preventable (25%). The adjusted incidence rate ratio for the intervention was 1.05 (95% confidence interval = 0.57-1.91). Our patients had a significant number of hospital and emergency department visits after diagnosis. Most visits were not related to recurrent venous thromboembolism or bleeding and of those that were, most were not preventable. Our multicomponent intervention did not decrease hospitalizations and emergency department visits.</p>
dc.identifier.submissionpathoapubs/4119
dc.contributor.departmentMeyers Primary Care Institute
dc.contributor.departmentDepartment of Emergency Medicine
dc.contributor.departmentDepartment of Population and Quantitative Health Sciences
dc.contributor.departmentDepartment of Medicine, Division of Hospital Medicine
dc.source.pages46958019900080


Files in this item

Thumbnail
Name:
0046958019900080.pdf
Size:
1.368Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright © The Author(s) 2020. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Except where otherwise noted, this item's license is described as Copyright © The Author(s) 2020. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).